In rare cases, an immune reaction has led to antibodies that caused a serious clotting disorder. But public health experts maintain the vaccine’s benefits far outweigh the risks for most people.
from NYT > Health https://ift.tt/320cfTG
April 10, 2021
Rose
Health - The New York Times, NYT > Health
No comments
Related Posts:
F.D.A. Requests Federal Investigation of Alzheimer’s Drug ApprovalThe agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules. from NYT > Health https://ift.tt/3yLVoCx … Read More
Scientists Press Case Against the Covid Lab Leak TheoryIn a review of recent studies and comparisons to other outbreaks, a group of virologists contends that there is more evidence to support a natural spillover from animals to humans. from NYT > Health https://ift.tt/3e4CJK7… Read More
A New Alzheimer’s Drug Offers More Questions Than AnswersThe approval of Aduhelm to treat Alzheimer’s disease has raised hope among older adults, but many doctors wonder if it is warranted. from NYT > Health https://ift.tt/3AFQTLE … Read More
The C.D.C. Issues New School Guidance, With Emphasis on Full ReopeningThe guidance acknowledges that many students have suffered from months of virtual learning. from NYT > Health https://ift.tt/3qYRbse … Read More
A Covid Test as Easy as BreathingScientists have been dreaming of disease-detecting breathalyzers for years. Has the time for the technology finally come? from NYT > Health https://ift.tt/3ASl3es … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment